Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
nitric oxide (inomax) (1 trial)
hydroxyurea (hydrea) (1 trial)
iron dextran (INFeD) (2 trials)
montelukast (singulair) (1 trial)
red blood cells (2 trials)
rituximab (rituxan) (1 trial)
s303 red blood cells (1 trial)
antihemophilic factor viii human (Hemofil M) (1 trial)
enoxaparin (lovenox) (1 trial)
regadenoson (lexiscan) (1 trial)
von Willebrand factor (recombinant) (Vonvendi) (1 trial)
Anemia (Phase 2)
Anemia, Sickle Cell (Phase 2)
Hemophilia A (Phase 2)
Inflammation (Phase 3)
Thalassemia (Phase 2)
Trials (10 total)
Trial APIs (11 total)